Much Ado About MACRA

Several clients and provider contacts expressed concern last week about how changing reimbursement methodologies may force IDNs and even community-based oncology medical groups to develop “population-based health” strategies for their patients. Client concerns include the risk of late-stage patients being diverted to hospice, and financial incentives to avoid prescribing branded cancer drugs. Providers we’ve spoken